Apyx Medical Corporation
APYX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $87,160 | $91,640 | $48,693 | $60,380 |
| - Cash | $25,135 | $29,301 | $31,011 | $31,741 |
| + Debt | $4,605 | $39,078 | $38,916 | $38,764 |
| Enterprise Value | $66,630 | $101,417 | $56,598 | $67,403 |
| Revenue | $12,877 | $11,373 | $9,430 | $14,222 |
| % Growth | 13.2% | 20.6% | -33.7% | – |
| Gross Profit | $8,297 | $7,083 | $5,665 | $8,964 |
| % Margin | 64.4% | 62.3% | 60.1% | 63% |
| EBITDA | -$332 | -$2,164 | -$2,609 | -$2,775 |
| % Margin | -2.6% | -19% | -27.7% | -19.5% |
| Net Income | -$1,984 | -$3,778 | -$4,150 | -$4,628 |
| % Margin | -15.4% | -33.2% | -44% | -32.5% |
| EPS Diluted | 0 | -0.093 | -0.12 | -0.12 |
| % Growth | 100% | 22.7% | 0% | – |
| Operating Cash Flow | -$3,536 | -$1,233 | -$702 | -$2,937 |
| Capital Expenditures | -$519 | -$265 | -$55 | -$245 |
| Free Cash Flow | -$4,055 | -$1,498 | -$757 | -$3,182 |